0N61.LSE Amplifon S.p.A.

Healthcare Commercial Services & Supplies London Exchange
30.39 EUR
Close of Nov 3, 2026
7.63 14.23
Market cap
EUR 6.71B
P/E
41.8x
P/B
-
ROE
-
Dividend yield
0.01%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2023.

Is 0N61.LSE undervalued?

Graham number

The Graham number of Amplifon S.p.A. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Amplifon S.p.A. fundamental analysis

No fundamental analysis for Amplifon S.p.A. yet.

Amplifon S.p.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Amplifon S.p.A.

Amplifon S.p.A. distributes hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. The company also offers Ampli-power and Ampli-mini hearing devices. Amplifon S.p.A. was founded in 19…

Full company profile